Authors: Wood, EM Woolley, I

Citation: Em. Wood et I. Woolley, Untitled, CLIN IMMUNO, 98(3), 2001, pp. 383-383

Authors: Michon, P Woolley, I Wood, EM Kastens, W Zimmerman, PA Adams, JH

Citation: P. Michon et al., Duffy-null promoter heterozygosity reduces DARC expression and abrogates adhesion of the P-vivax ligand required for blood-stage infection, FEBS LETTER, 495(1-2), 2001, pp. 111-114

Authors: Zimmerman, PA Woolley, I Masinde, GL Miller, SM McNamara, DT Hazlett, F Mgone, CS Alpers, MP Genton, B Boatin, BA Kazura, JW

Citation: Pa. Zimmerman et al., Emergence of FYA(null) in a Plasmodium vivax-endemic region of Papua New Guinea, P NAS US, 96(24), 1999, pp. 13973-13977

Authors: Valdez, H Lederman, MM Woolley, I Walker, CJ Vernon, LT Hise, A Gripshover, BM

Citation: H. Valdez et al., Human immunodeficiency virus 1 protease inhibitors in clinical practice - Predictors of virological outcome, ARCH IN MED, 159(15), 1999, pp. 1771-1776